BIYA vs. MXCT, III, EGHT, LTBR, AHG, PHLT, TCX, PAYS, OPRX, and OABI
Should you be buying Baiya International Group stock or one of its competitors? The main competitors of Baiya International Group include MaxCyte (MXCT), Information Services Group (III), 8X8 (EGHT), Lightbridge (LTBR), Akso Health Group (AHG), Performant Healthcare, Inc. - Common Stock (PHLT), Tucows (TCX), Paysign (PAYS), OptimizeRx (OPRX), and OmniAb (OABI). These companies are all part of the "business services" industry.
Baiya International Group vs.
Baiya International Group (NASDAQ:BIYA) and MaxCyte (NASDAQ:MXCT) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, community ranking, profitability, valuation, risk, earnings, media sentiment and dividends.
In the previous week, Baiya International Group had 2 more articles in the media than MaxCyte. MarketBeat recorded 2 mentions for Baiya International Group and 0 mentions for MaxCyte. MaxCyte's average media sentiment score of 0.18 beat Baiya International Group's score of 0.00 indicating that MaxCyte is being referred to more favorably in the news media.
MaxCyte received 12 more outperform votes than Baiya International Group when rated by MarketBeat users.
68.8% of MaxCyte shares are held by institutional investors. 3.0% of MaxCyte shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Baiya International Group has a net margin of 0.00% compared to MaxCyte's net margin of -78.36%. Baiya International Group's return on equity of 0.00% beat MaxCyte's return on equity.
Baiya International Group has higher earnings, but lower revenue than MaxCyte.
MaxCyte has a consensus price target of $7.50, indicating a potential upside of 235.57%. Given MaxCyte's stronger consensus rating and higher possible upside, analysts plainly believe MaxCyte is more favorable than Baiya International Group.
Summary
MaxCyte beats Baiya International Group on 9 of the 13 factors compared between the two stocks.
Get Baiya International Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for BIYA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Baiya International Group Competitors List
Related Companies and Tools
This page (NASDAQ:BIYA) was last updated on 5/21/2025 by MarketBeat.com Staff
